What we do Centenial Surgical Suture Ltd manufactures and sells surgical sutures and medical devices, specializing in cardiovascular sutures with over 300 product codes. |
Founded in 1,995 |
Market share Leading player in Indian cardiovascular suture market with significant domestic presence and growing export footprint. |
Problem solved Provides high-quality, innovative surgical sutures and atraumatic needles addressing global and Indian cardiovascular surgery needs. |
Top clients or who we serve Primarily B2B serving surgeons, hospitals, and healthcare institutions focused on cardiovascular and surgical applications. |
Key management Vijay Majrekar (CEO & MD), Anuradha Kashikar (CFO & Executive Director), Devraj T. Poojary (Executive Director). |
Our journey and innovations Since 1995, continuous R&D in atraumatic needles and sutures, expanding product portfolio including surgical threads and medical devices. |
Where we operate Mainly India with incremental business from international markets. |
Top products or what we offer Absorbable and non-absorbable sutures, atraumatic needles, female urinary incontinence sets, titanium haemostatic clips, cardiovascular surgical tools. |
Top brands - |
Raw materials needed Surgical thread raw materials, needles, synthetic and natural suture materials. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue primarily from cyclical sales aligned with surgical and healthcare demand. |
Our industry position Significant market position in Indian cardiovascular sutures, competing with domestic and global medical device players. |
Financial highlights FY 2024-25 Revenue: Rs 53.52 Cr; Net Loss: Rs 1.46 Cr; faced pricing pressures and rising raw material costs. |
Geographical revenue split Approximately 49.35 Cr from India and 4.17 Cr from outside India for FY 2024-25. |
Order book - |
Whats driving growth Innovation in atraumatic needle technology, product development, and increasing domestic healthcare demand. |
Our future plans Scaling up production of surgical threads and new medical devices under development. |
Our green promise - |
Our people and values Focus on employee skills development, diversity, inclusion, and safe workplace culture. |
Key challenges ahead Intensified competition, pricing pressures, raw material cost inflation, and regulatory hurdles. |
Interesting facts Offers over 300 cardiovascular suture product codes covering coronary artery bypass graft (CABG) applications. |
Risks and strategy Risk from competition and regulatory challenges; mitigating via R&D, cost control, and portfolio focus. |
